Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
AT 130 REF: 4Z-B-118003CAS: 211364-06-6 | - - - | To inquire | Tue 14 Jan 25 | |
AT-130 REF: TM-T26674CAS: 211364-06-6 | 98.62% | 42.00 €~674.00 € | Tue 14 Jan 25 | |
AT-130 REF: 3D-LIA36406CAS: 211364-06-6 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: 4Z-B-118003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
AT-130
CAS:211364-06-6
AT-130: Strong HBV inhibitor (IC50 0.13 μM), low toxicity in HepAD38, hinders RNA packaging.
Formula:
C22H22BrN3O5
Purity:
98.62%
Color and Shape:
Solid
Molecular weight:
488.33
Ref: TM-T26674
1mg | 42.00 € | ||
5mg | 92.00 € | ||
10mg | 133.00 € | ||
25mg | 229.00 € | ||
50mg | 342.00 € | ||
100mg | 514.00 € | ||
200mg | 674.00 € | ||
1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
AT-130
CAS:211364-06-6
AT-130 is a peptide that binds to the CCR5 receptor, which is found on the …
Formula:
C22H22BrN3O5
Purity:
Min. 95%
Molecular weight:
488.3 g/mol
Ref: 3D-LIA36406
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025